Ozone therapy in extractive surgery on patients treated with bisphosphonates

Journal of Craniofacial Surgery

Volumn 18, Issue 5, 2007, Pages 1068-1070

  Agrillo, Alessandro ^a   Sassano, Pierpaolo ^a   Rinna, Claudio ^a   Priore, Paolo ^a,b   Iannetti, Giorgio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

Bisphosphonates; Extractive surgery; ONJ; Ozone therapy

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; BONE NECROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; JAW; MALE; OZONE THERAPY; PRIORITY JOURNAL; SAFETY; TOOTH EXTRACTION; TREATMENT OUTCOME;

AGED; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEONECROSIS; OXIDANTS, PHOTOCHEMICAL; OZONE; TOOTH EXTRACTION;

EID: 34948839404     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e3181572609     Document Type: Article

References (15)

1. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115-1117
2. Ruggiero SL, Mehrotra B, Rosenberg TJ, et al. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62:527-534
3. Bagan JV, Murillo J, Jimenez Y, et al. Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med 2005;34:120-123
4. Cheng A, Mavrokokki A, Carter G, et al. The dental implications of bisphosphonates and bone disease. Aust Dent J 2005;Suppl 2:4-13
5. Migliorati CA, Schubrt MM, Peterson DE, et al. Bisphosphonateassociated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 2005;104:83-93
6. Carter G, Goss AN, Doecke C, et al. Bisphosphonates and avascular necrosis of the jaw: a possible association. Med J Aust 2005;182:413-415
7. Purcell PM, Boyd IW. Bisphosphonates and osteonecrosis of the jaw. Med J Aust 2005;182:417-418
8. Durie BG, Katz M, Crowley J, et al. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 2005;353:99-102
9. Package Insert Revisions re: Osteonecrosis of the jaw: Zometa (zoledronic acid) injection and Aredia (pamidronate disodium) injection. Oncologic Drugs Advisory Committee Meeting, March 4, 2005
10. Migliorati CA, Casiglia J, Epstein J, et al. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc 2005;136:1658-1668
11. Agrillo A, Petrucci MT, Tedaldi M, et al. New therapeutic protocol in the treatment of avascular necrosis of the jaws. J Craniofacial Surg 2006;17:1080-1083
12. Marx RE, Sawatary N, Fortin M, et al. Bisphosphonate induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63:1567-1575
13. Badros A, Weikel D, Salama A, et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 2006;24:945-952
14. Bagan JV, Jimenez Y, Murillo J, et al. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol 2006;42:327-329
15. Vannucchi AM, Ficarra G, Antonioli E, et al. Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma. Br J Haematol 2005;128:738